Old Web
English
Sign In
Acemap
>
authorDetail
>
Craig Wakeford
Craig Wakeford
Biogen Idec
Medicine
Multiple sclerosis
Disease
Physical therapy
Cost–benefit analysis
10
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis.
2020
Neurology and Therapy
Maria Pia Sormani
Robert Wolff
Shona H. Lang
Steven Duffy
Robert Hyde
Elizabeth Kinter
Craig Wakeford
Gavin Giovannoni
Jos Kleijnen
Show All
Source
Cite
Save
Citations (2)
A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis.
2020
Neurology and Therapy
Gavin Giovannoni
Shona H. Lang
Robert Wolff
Steven Duffy
Robert Hyde
Elizabeth Kinter
Craig Wakeford
Maria Pia Sormani
Jos Kleijnen
Show All
Source
Cite
Save
Citations (3)
PND16 PREFERENCES OF PATIENTS FOR FEATURES OF INJECTABLE, ORAL, AND INFUSED DISEASE-MODIFYING TREATMENTS FOR RELAPSE-REMITTING MULTIPLE SCLEROSIS
2019
Value in health regional issues
Christine Poulos
Craig Wakeford
Elizabeth Kinter
Brennan Mange
Thomas Schenk
Show All
Source
Cite
Save
Citations (0)
Reconsidering the economic value of multiple sclerosis therapies.
2016
The American Journal of Managed Care
Tiffany Shih
Craig Wakeford
Meletiche D
Jesse Sussell
Chung A
Liu Y
Shim Jj
Darius N. Lakdawalla
Show All
Source
Cite
Save
Citations (4)
Can small markets compete? Empirics on competitive balance in the NHL
2003
Craig Wakeford
Show All
Source
Cite
Save
Citations (0)
1